Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $169,400 | 73 | 56.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,173 | 23 | 22.2% |
| Consulting Fee | $29,187 | 16 | 9.8% |
| Travel and Lodging | $19,461 | 46 | 6.5% |
| Food and Beverage | $6,097 | 58 | 2.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,000 | 1 | 1.0% |
| Grant | $2,472 | 2 | 0.8% |
| Unspecified | $2,276 | 4 | 0.8% |
| Education | $18.34 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $175,252 | 106 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $91,573 | 81 | $0 (2024) |
| Bracco Diagnostics Inc. | $14,220 | 7 | $0 (2024) |
| Boston Scientific Corporation | $8,937 | 14 | $0 (2020) |
| Itamar Medical Inc | $5,673 | 6 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $1,511 | 3 | $0 (2024) |
| ZOLL Medical Corporation | $442.50 | 1 | $0 (2021) |
| Inspire Medical Systems, Inc. | $175.05 | 1 | $0 (2017) |
| Amarin Pharma Inc. | $125.00 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $120.29 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100,874 | 85 | E.R. Squibb & Sons, L.L.C. ($68,980) |
| 2023 | $61,520 | 41 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($37,371) |
| 2022 | $42,152 | 25 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($31,600) |
| 2021 | $39,420 | 20 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($36,900) |
| 2020 | $20,537 | 11 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($17,400) |
| 2019 | $16,735 | 18 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($12,884) |
| 2018 | $10,572 | 13 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($6,078) |
| 2017 | $6,273 | 11 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($4,003) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $312.66 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $10.24 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $930.75 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 12/07/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $468.66 | General |
| 12/07/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $300.48 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $80.00 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $28.23 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $21.04 | General |
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,166.00 | General |
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,645.00 | General |
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,604.00 | General |
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,430.00 | General |
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.20 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $1,072.12 | General |
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $68.17 | General |
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $684.01 | General |
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $356.79 | General |
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $166.50 | General |
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $36.15 | General |
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $900.50 | General |
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.09 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SONATA-HCM | Lexicon Pharmaceuticals, Inc. | $1,511 | 3 |
| A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM) | E.R. Squibb & Sons, L.L.C. | $764.06 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,183 | 2,565 | $649,215 | $99,572 |
| 2022 | 13 | 1,815 | 1,997 | $541,673 | $87,411 |
| 2021 | 11 | 2,121 | 2,367 | $615,911 | $103,013 |
| 2020 | 9 | 1,552 | 1,715 | $454,298 | $79,489 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 934 | 990 | $362,102 | $57,239 | 15.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 104 | 106 | $59,907 | $9,966 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 54 | $37,206 | $6,165 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 37 | $36,223 | $6,135 | 16.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 171 | 234 | $32,811 | $5,081 | 15.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 391 | 557 | $24,508 | $3,998 | 16.3% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 11 | 12 | $14,172 | $2,435 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $10,087 | $1,719 | 17.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 81 | 116 | $16,124 | $1,532 | 9.5% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 141 | 143 | $31,603 | $1,497 | 4.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 125 | 163 | $6,786 | $1,045 | 15.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 13 | $4,186 | $946.79 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $6,916 | $796.86 | 11.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 40 | 40 | $3,960 | $623.60 | 15.7% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 32 | 33 | $1,769 | $282.11 | 15.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 42 | 42 | $854.28 | $110.46 | 12.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 1,006 | 1,055 | $385,877 | $62,515 | 16.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 81 | 81 | $45,778 | $7,885 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 26 | $17,914 | $3,092 | 17.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 284 | 364 | $16,016 | $2,617 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 29 | $14,326 | $2,479 | 17.3% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2022 | 11 | 11 | $12,991 | $2,365 | 18.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 87 | 99 | $13,882 | $2,232 | 16.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $6,842 | $1,152 | 16.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2022 | 60 | 60 | $5,940 | $952.62 | 16.0% |
About Dr. Ronald Wharton, M.D
Dr. Ronald Wharton, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669430633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Wharton, M.D has received a total of $298,083 in payments from pharmaceutical and medical device companies, with $100,874 received in 2024. These payments were reported across 224 transactions from 12 companies. The most common payment nature is "Honoraria" ($169,400).
As a Medicare-enrolled provider, Wharton has provided services to 7,671 Medicare beneficiaries, totaling 8,644 services with total Medicare billing of $369,485. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 05/01/2006
- Last Updated 08/15/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669430633
Products in Payments
- LifeVest (Device) $175,252
- Lumason (Drug) $11,220
- WATCHMAN (Device) $6,465
- CAMZYOS (Drug) $6,121
- ProHance (Drug) $3,000
- WatchPATONE (Device) $2,106
- WatchPAT (Device) $2,078
- WatchPat (Device) $1,489
- GENERAL TACHY (Device) $1,250
- GENERAL TACHY (Device) $1,222
- Inspire Upper Airway Stimulation System (Device) $175.05
- Vascepa (Drug) $125.00
- ENTRESTO (Drug) $120.29
- DEFINITY (Drug) $22.98
- XARELTO (Drug) $18.34
- Definity (Drug) $13.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Joshua Kerstein, Md, MD
Cardiovascular Disease — Payments: $216,817